Deal Library / Pharma BD Deal Intelligence

Astellas Pharma Inc. — Pharma Deals

The Pharma Closeout tracks 18 deals, $17.9B in disclosed deal value, 10 with a post-close Outcome Score for Astellas Pharma Inc..

Median Critic Score: 83  ·  Median Outcome Score: 40

Best outcome: Astellas Pharma Inc. / Seagen Inc. (95)  ·  Weakest outcome: Astellas Pharma Inc. / Maxygen, Inc. (Perseid Therapeutics stake) (11)

All 18 deals

• Astellas Pharma Inc. / Seagen Inc. — 2009 · $4.5B · Worked — the deal delivered on its rationale.
• Astellas Pharma Inc. / Ganymed Pharmaceuticals — 2016 · $1.4B · Worked — the deal delivered on its rationale.
• Astellas Pharma Inc. / Sangamo Therapeutics, Inc. — 2026 · $50M · Largely worked — most objectives met.
• Astellas Pharma Inc. / Ogeda SA — 2017 · $850M · Mixed — partial payoff, real shortfalls.
• Astellas Pharma Inc. / Ocata Therapeutics, Inc. — 2015 · $379M · Underwhelmed — fell short of the thesis.
• Astellas Pharma Inc. / Optimer Pharmaceuticals, Inc. — 2012 · $90M · Underwhelmed — fell short of the thesis.
• Astellas Pharma Inc. / OSI Pharmaceuticals — 2010 · $4.0B · Underwhelmed — fell short of the thesis.
• Astellas Pharma Inc. / Audentes Therapeutics — 2019 · $3.0B · Did not work — the deal failed to deliver.
• Astellas Pharma Inc. / Mitobridge, Inc. — 2018 · $450M · Did not work — the deal failed to deliver.
• Astellas Pharma Inc. / Maxygen, Inc. (Perseid Therapeutics stake) — 2011 · $76M · Did not work — the deal failed to deliver.
• Astellas Pharma Inc. / Vir Biotechnology — 2026
• Astellas Pharma Inc. / Evopoint — 2025
• Astellas Pharma Inc. / Kelonia Therapeutics — 2024
• Astellas Pharma Inc. / Poseida Therapeutics Inc. — 2024 · $550M
• Astellas Pharma Inc. / UMass Chan Medical School — 2024
• Astellas Pharma Inc. / AviadoBio Ltd. — 2024 · $2.2B
• Astellas Pharma Inc. / Mass General Brigham — 2024
• Astellas Pharma Inc. / Potenza Therapeutics, Inc. — 2019 · $405M

← Deal Library  ·  Interactive search  ·  How we score deals